Usefulness of the MESH score in a European hepatocellular carcinoma cohort

Table 2 Comparison of performances of each scoring systems in the entire cohort

Score	Discriminatory ability linear trend test		Homogeneity likelihood ratio test		Akaike Information Criterion	C-index (95%CI)
	LT (χ²)	P value	LR (χ²)	P value
MESH	145.125	< 0.0001	372.4846	< 0.0001	4145.284	0.830
BCLC	137.845	< 0.0001	327.5024	< 0.0001	4194.266	0.806
HKLC	104.966	< 0.0001	387.2755	< 0.0001	4146.493	0.811
CLIP	108.423	< 0.0001	341.3485	< 0.0001	4101.288	0.816
NIACE	144.998	< 0.0001	425.6698	< 0.0001	4092.099	0.853

MESH: Model to estimate survival for HCC; BCLC: Barcelona Clinic Liver Cancer; HKLC: Hong Kong Liver Cancer; CLIP: Cancer of the Liver Italian Program; NIACE: Tumor Nodularity, Infiltrative nature of the tumor, Serum Alpha-fetoprotein level, Child-Pugh stage, Eastern Cooperative Oncology Group Performance Status; LT: Linear trend; LR: Likelihood ratio.